PLATFORMS
Gem Forlab operates on three integrated platforms, designed to offer customized solutions to perfectly meet our customers’ needs.
IMCB
IMCB
MSPP
MSPP
CONSULTANCY
CONSULTANCY
QUALITY AND REGULATORY
We are a GLP certified and AIFA-recognized Testing Centre, listed in the OsSC register as a private laboratory qualified for the analysis of samples from clinical studies (phases I-II-III)
GLP CERTIFICATION
GCP AUTHORIZATION
QUALITY MANAGEMENT SYSTEM
PARTNERSHIP

Since 1980, Gem Chimica offers customized solutions in several sectors: professional cleaning, food safety management, environmental health, renewable energy, water treatment, chemical, physical and microbiological analysis.

The consultancy company specialising in regulatory toxicology, created to take your business far, shedding light on the complex and changing regulatory sea and helping you ensure the safety of the products you want to bring to market.

Galileo Research is a non-clinical Contract Research Organization (CRO). Our solutions meet global regulatory requirements and include studies on toxicology, biocompatibility, efficacy/performance and mechanisms of action.

Abich has been providing research and analysis services mainly to manufacturers of cosmetics, medical products. In addition, Abich provides, actively researches and promotes the validation of in-vitro methods as an alternative to animal testing, in line with current regulations.

VETSPIN is a Contract Research Organization founded in 2004 as a spinoff of the University of Bologna. VETSPIN performs Pre-Clinical and Clinical trials for regulatory purposes in farm animals.

Fluody is a chemical Contract Research Organization (cCRO), located in Villanova Mondovì (CN), Italy. Our expertise is synthetic organic chemistry: we offer R&D services, process development, custom synthesis and contract manufacturing.

Since 2009, we have been the hub for the growth and success of Piedmont's health and life sciences value chain. Our network of excellence brings together key players in the world of innovation: we are a network that collaborates and produces value.

Bridge To Lab (B2L) is a spin-off from the University of Turin offering R&D services in the pharmaceutical, nutraceutical, dermocosmetic, and medical device sectors, operating within a non-certified preclinical setting.
This approach allows us to deliver highly customized solutions at competitive costs, by developing advanced biotechnological protocols and leveraging academic know-how through a network of specialized laboratories.
B2L is the ideal partner for companies seeking flexible, efficient, and high-quality innovation.